نظرة سريرية عامة
TIMI risk scoring is a bedside decision-support calculation used to standardize a defined part of clinical assessment. It offers separate validated models for UA/NSTEMI and STEMI; the correct syndrome must be selected because criteria, weighting, and outcomes differ. The result should be interpreted with the patient’s presentation, baseline function, serial observations, laboratory method, medication exposure, and the protocol used by the treating institution. It is an aid to communication and risk stratification rather than an independent diagnosis or treatment order.
Enter contemporaneous values and confirm every unit before calculating. When physiology is changing, repeat assessment and prioritize the clinical trajectory over a single number. Document the input values alongside the result so another clinician can reproduce the calculation and recognize assumptions. Thresholds describe populations and do not remove the need to investigate discordant symptoms, examination findings, imaging, or biomarkers.
دواعي الاستخدام
- Confirmed or strongly suspected acute coronary syndrome
- Syndrome-specific short-term risk communication
القيود والسلامة
The STEMI model arose in a fibrinolysis-era population and the UA/NSTEMI model predicts a composite outcome, so percentages may not match contemporary care. Validation cohorts, case mix, prevalence, and treatment era affect observed event rates. Pregnancy, extremes of age or body composition, critical illness, and major comorbidity may reduce transportability unless specifically represented in the original model. Do not extrapolate beyond the stated population or substitute this estimate for a validated local pathway.
Before acting, check for missing data, measurement error, competing diagnoses, contraindications, and time-sensitive emergencies. A low-risk label never overrides clinician concern; a high-risk label does not prove the target condition. Discuss consequential decisions with the appropriate senior or specialty team and use current regional guidance.
- Do not use before establishing the appropriate ACS phenotype
- Never delay ECG, reperfusion, antithrombotic treatment, or cardiology activation
المعادلة
UA/NSTEMI: seven 1-point variables (0–7). STEMI: weighted age, risk history, SBP, heart rate, Killip class, weight, anterior STE/LBBB, and treatment delay (0–14).
تفسير النتائج
- UA/NSTEMI 0–2 — Lower: Lower 14-day composite event rate. Guideline-directed ACS care and individualized invasive assessment.
- UA/NSTEMI 3–4 — Intermediate: Increasing ischemic event risk. Early specialist and invasive-strategy assessment.
- UA/NSTEMI 5–7 — High: High composite event rate. High-acuity ACS management.
- STEMI 0–2 / 3–5 / ≥6 — Lower / intermediate / high: Increasing 30-day mortality. Immediate reperfusion pathway regardless of score.
المراجع
- Antman EM, et al. TIMI risk score for UA/NSTEMI. JAMA. 2000.
- Morrow DA, et al. TIMI risk score for STEMI. Circulation. 2000.
الأسئلة الشائعة
Are the STEMI and NSTEMI scores interchangeable?
No. They use different variables, weights, and predicted outcomes.
Can TIMI decide whether a STEMI is reperfused?
No. Eligible STEMI requires immediate reperfusion assessment regardless of risk score.
What are the CAD risk factors?
Common original factors include hypertension, diabetes, smoking, dyslipidemia, and family history of premature CAD.